CC(=O)O[C@H]1CC2C(C3CC[C@H](C(C)CCC(N)=O)[C@]31C)[C@H](OC(C)=O)C[C@@H]1CC3(CC[C@]21C)OOC1(CCC(C)CC1)OO3
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?